These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [New derivatives of eremomycin containing (15)n or f atoms for NMR study]. Solov'eva SE; Printsevskaia SS; Olsuf'eva EN; Batta G; Preobrazhenskaia MN Bioorg Khim; 2008; 34(6):831-9. PubMed ID: 19088759 [TBL] [Abstract][Full Text] [Related]
23. Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides. Linsdell H; Toiron C; Bruix M; Rivas G; Menéndez M J Antibiot (Tokyo); 1996 Feb; 49(2):181-93. PubMed ID: 8621360 [TBL] [Abstract][Full Text] [Related]
24. Quantum simulations of the structure and binding of glycopeptide antibiotic aglycons to cell wall analogues. Lee JG; Sagui C; Roland C J Phys Chem B; 2005 Nov; 109(43):20588-96. PubMed ID: 16853665 [TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationship studies of a series of antiviral and antibacterial aglycon derivatives of the glycopeptide antibiotics vancomycin, eremomycin, and dechloroeremomycin. Printsevskaya SS; Solovieva SE; Olsufyeva EN; Mirchink EP; Isakova EB; De Clercq E; Balzarini J; Preobrazhenskaya MN J Med Chem; 2005 Jun; 48(11):3885-90. PubMed ID: 15916441 [TBL] [Abstract][Full Text] [Related]
26. [The structure and antimicrobial activity of the partial degradation products of the antibiotic eremomycin]. Berdnikova TF; Lomakina NN; Olsuf'eva EN; Aleksandrova LG; Potapova NP; Rozynov BV; Malkova IV; Orlova GI Antibiot Khimioter; 1991 Jun; 36(6):28-31. PubMed ID: 1910324 [TBL] [Abstract][Full Text] [Related]
32. N'-(alpha-aminoacyl)- and N'-alpha-(N(alpha)-alkylamino)acyl derivatives of vancomycin and eremomycin. I. Synthesis of N'-(alpha-aminoacyl)- and N'-alpha-(N(alpha)-alkylamino)acyl derivatives of vancomycin and eremomycin by selective aminoacylation of the amino sugar of the disaccharide branch. Preobrazhenskaya MN; Olsufyeva EN; Miroshnikova OV; Plattner JJ; Chu D; Printsevskaya SS J Antibiot (Tokyo); 2007 Apr; 60(4):235-44. PubMed ID: 17456973 [TBL] [Abstract][Full Text] [Related]
33. Modification and inhibition of vancomycin group antibiotics by formaldehyde and acetaldehyde. Heck AJ; Bonnici PJ; Breukink E; Morris D; Wills M Chemistry; 2001; 7(4):910-6. PubMed ID: 11288883 [TBL] [Abstract][Full Text] [Related]
34. Use of capillary electrophoresis to measure dimerization of glycopeptide antibiotics. LeTourneau DL; Allen NE Anal Biochem; 1997 Mar; 246(1):62-6. PubMed ID: 9056183 [TBL] [Abstract][Full Text] [Related]
35. Investigation of complexes between some glycopeptide antibiotics and bacterial cell-wall analogues by electrospray- and capillary zone electrophoresis/electrospray-mass spectrometry. Hamdan M; Curcuruto O; Di Modugno E Rapid Commun Mass Spectrom; 1995; 9(10):883-7. PubMed ID: 7670152 [TBL] [Abstract][Full Text] [Related]
36. Binding of a dimeric derivative of vancomycin to L-Lys-D-Ala-D-lactate in solution and at a surface. Rao J; Yan L; Lahiri J; Whitesides GM; Weis RM; Warren HS Chem Biol; 1999 Jun; 6(6):353-9. PubMed ID: 10375541 [TBL] [Abstract][Full Text] [Related]
37. A new type of chemical modification of glycopeptides antibiotics: aminomethylated derivatives of eremomycin and their antibacterial activity. Pavlov AY; Lazhko EI; Preobrazhenskaya MN J Antibiot (Tokyo); 1997 Jun; 50(6):509-13. PubMed ID: 9268008 [TBL] [Abstract][Full Text] [Related]
38. Chemical modification of the eremomycin antibiotic. Formation of a cyclic covalent dimer. Sztaricskai F; Batta G; Dinya Z; Miroshnikova OV; Preobrazhenskaya MN; Hernádi F; Koncz A; Boda Z J Antibiot (Tokyo); 2001 Mar; 54(3):314-9. PubMed ID: 11372789 [No Abstract] [Full Text] [Related]
40. Conformational studies of resin-bound vancomycin and the complex of vancomycin and Ac2-L-Lys-D-Ala-D-Ala. Yao NH; He WY; Lam KS; Liu G J Comb Chem; 2005; 7(1):123-9. PubMed ID: 15638491 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]